TD
TNDM
HealthcareTandem Diabetes Care
Price Chart
Loading...
Market Data
Revenue TTMXBRL
—
Net IncomeXBRL
—
Gross MarginXBRL
—
EPS (Diluted)XBRL
—
No analysis generated yet. Run the pipeline for this company.
AI-extracted key facts from press releases and SEC filings. Significance 1–10.
7
GuidanceBullishPer-CompanyMar 22, 2026
Tandem Diabetes Targets 65% Gross Margin by 2026 via Pharmacy Channel Shift
- ▸Targeting 65% gross margin, accelerated by pharmacy channel transition
- ▸Q4 gross margin reached record 58%
- ▸Projecting 60% gross margin exit rate by Q4 2024
- ▸Pharmacy sales expected to reach 70% of total revenue within 3 years
- ▸Secured contracts with three major PBMs covering 80% of lives